Closure devices and vascular complications among percutaneous coronary intervention patients receiving enoxaparin, glycoprotein IIb/IIIa inhibitors, and clopidogrel-Reference-Cited by-同舟云学术

Closure devices and vascular complications among percutaneous coronary intervention patients receiving enoxaparin, glycoprotein IIb/IIIa inhibitors, and clopidogrel

Published:2005 Issue:3 Volume:64 Page:369-372
ISSN:1522-1946
Container-title:Catheterization and Cardiovascular Interventions
language:en
Short-container-title:Cathet. Cardiovasc. Intervent.

Author:

Exaire J. Emilio,Tcheng James E.,Kereiakes Dean J.,Kleiman Neal S.,Applegate Robert J.,Moliterno David J.,

Publisher

Wiley

Subject

Cardiology and Cardiovascular Medicine,Radiology, Nuclear Medicine and imaging,General Medicine

Reference9 articles.

1. Vascular closure devices in patients treated with anticoagulation and iib/iiia receptor inhibitors during percutaneous revascularization

2. Safety of femoral closure devices after percutaneous coronary interventions in the era of glycoprotein IIb/IIIa platelet blockade

3. Modifiable Risk Factors for Vascular Access Site Complications in the IMPACT II Trial of Angioplasty With Versus Without Eptifibatide

Cited by 20 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Vascular Access and Closure;Cardiovascular Intervention;2016

2. Risk Factors for Puncture Site Complications After Endovascular Procedures in Patients With Peripheral Arterial Disease;Vascular and Endovascular Surgery;2015-09-30

3. Full conversion from transfemoral to transradial approach for percutaneous coronary interventions results in a similar success rate and a rapid reduction of in-hospital cardiac and vascular major events;EuroIntervention;2013-07

4. Access Management and Closure Devices;Textbook of Interventional Cardiology;2012

5. Quality Improvement in the Catheterization Laboratory: Redesigning Patient Flow for Improved Outcomes;Critical Care Nurse;2010-04-01